Astellas Bids US$1 B for CV Therapeutics

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 1 (Table of Contents)

Published: 27 Jan-2009

DOI: 10.3833/pdr.v2009.i1.92     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Astellas made a hostile bid for CV Therapeutics...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details